Venture-Backed Startups

Toronto Metropolitan University is an academic institution focused on combining academic excellence with real-world impact, emphasizing experiential learning, research that addresses societal challenges, and fostering innovation and entrepreneurship.

3 investors

DMZ Launchpad is a free online skills-development platform offering courses that teach entrepreneurship, from idea to launch, aimed at aspiring and early-stage founders including first-year students. It is an educational program run by the DMZ.

1 investor

Dagens Nyheter (DN) is a Swedish daily news publication covering national and international news, politics, sports, culture, opinion, and lifestyle. It publishes articles online for readers in Sweden.

1 investor

Investment Manager is an AI-powered platform that converts property management reports into structured investment data for real estate portfolio management, enabling investors to validate, analyze, and gain insights from asset performance across their holdings.

7 investors

0 investors

DNA Energy provides technology that connects energy assets to commercial outcomes for businesses and energy utilities managing the energy transition. Its platform supports multiple asset connection methods (software/API, wired/networked, wireless mesh) and complies with global control standards such as IEEE 2030.5, CSIP/CSIP AUS, and AS/NZS 4755.

1 investor

0 investors

Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium. It focuses on oral mRNA medicines.

2 investors

0 investors

0 investors

0 investors

DNA Block develops REPLIKANT Chat, a platform for interactive conversations with 3D AI characters in dynamic environments. The product is available on Steam and Epic Games with editor tools for customization and cloud storage capabilities.

2 investors

DNA Gensee runs a DNA analysis laboratory and R&D consultancy that identifies plant and algae species in raw materials, ingredients, and finished products using molecular biology techniques. It serves industrial manufacturers using plants or algae, verifying botanical and geographic authenticity, traceability, safety, and quality of natural extracts.

1 investor

DNAiTECH develops molecular diagnostic tests for point-of-care applications, including its PLACID platform combining paper-based LAMP-CRISPR technology, serving both medical and agricultural diagnostic markets. The company focuses on accessible diagnostics for conditions including ME/CFS, Long COVID, and veterinary/agritech applications.

1 investor

DNAnexus operates a cloud platform for managing, analyzing, and collaborating on multiomic and clinical data, supporting bioinformatics workflows, AI/ML analytics, and cohort analysis. It serves biomedical organizations including pharmaceutical companies, clinical diagnostics providers, academic medical centers, and biobanks, with built-in GxP and regulatory compliance.

6 investors

0 investors

DNAsafe provides an API for healthcare applications to perform computations on encrypted data while keeping unencrypted data on users' devices, enabling privacy-preserving healthcare data processing.

1 investor

DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications. The page lists the company's leadership, board members, and staff.

2 investors

DNAsimple connects individuals with medical research studies, matching them to researchers' requests and paying rewards for contributing biological samples (blood, urine) and completing health surveys. It lets participants share their medical records and de-identified health data, and complete studies at home or with a visiting clinician.

1 investor

DNAstack builds Omics AI, a software suite that lets data custodians connect, protect, and share omics and health data across federated networks while enabling researchers to discover, access, and analyze it with AI tools. It serves genomics and health research organizations, including national and international research networks in areas such as pandemic surveillance, neuroscience, rare disease, and oncology, using open GA4GH standards.

1 investor

2 investors

DNF Solution is a specialist in CVD/ALD precursor materials for semiconductor circuit formation. The company develops and supplies core materials essential to semiconductor manufacturing and advances in electronic materials.

2 investors

Korean AI company building Seahorse, a vector database, and Mnemos, an on-device LLM appliance, alongside its DNA models.

1 investor

dNovo develops direct reprogramming technology to convert skin, blood, or fat cells into new stem cells, targeting age-related stem cell depletion. The company aims to address aging through cellular regeneration for consumers.

2 investors